GENE ONLINE|News &
Opinion
Blog

Bispecific Antibody
JPM 2026 Recap: Capital Markets Reopen, AI Moves to the Last Mile, Metabolic Stakes Climb
2026-01-15
Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines
2026-01-09
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
F-star Announces Collaboration with Takeda to Develop Next Generation Immunotherapeutics
2023-07-09
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Janssen Scores Another Multiple Myeloma FDA Approval with Tecvayli
2022-10-25
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
1 2
LATEST
Alliance for Clinical Trials in Oncology Highlights Research Initiatives on World Breast Cancer Research Day
2026-08-18
Great Science Is Only the First Step Toward U.S. Healthcare Success
2026-08-18
European Patent Office Grants Godavari Biorefineries Patent for Anti-Cancer Drug Formulation
2026-08-18
One in 20 Australian Women Now Receive Intravenous Iron Infusions
2026-08-18
UL Research Institutes Appoints Dr. Chao-Yang Wang to Lead Electrochemical Safety Research Institute
2026-08-17
SUNY Polytechnic Institute Receives $15,000 Grant to Develop Mechanical Lung Model
2026-08-17
MetaboAnalyst 6.0 Released for LC-MS2 Environmental Exposure and Dose-Response Analysis
2026-08-17
Scroll to Top